GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
- Response deadline
- Oct 30, 2026 Due in 12 days
- Date posted
- Jun 18, 2026
- Source
- Open notice
Description
The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. The purpose of this Notice of Funding Opportunity is to establish the GREGoRi Technology Integration Center, which will enable the development of standards and best practices for applying new and emerging molecular methods in rare disease diagnosis. A major deliverable of the Center will be a multidimensional dataset that can be used for the development and benchmarking of novel tools and strategies that facilitate rare disease diagnosis.
Classifications
- NAICS93.172
Documents (1)
- DownloadRFA-HG-27-012-Full-Announcement.htmltext/html;charset=UTF-8146 KB
Contacts
Similar contracts
- Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)Due Dec 14, 2026
- Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)Due Dec 14, 2026
- IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)Due Dec 14, 2026
- Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)Due Dec 14, 2026
- GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)Due Oct 30, 2026
- GREGoRi Innovation Projects (U01 Clinical Trial Optional)Due Oct 30, 2026